Search PDMR transactions

Notifier
Name
Alexander Brising
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Alexander Brising
Position
Business Development Director
Initial notification
Yes
Amendment
No
Details of amendment
Issuer
Name of issuer
EQL Pharma AB
LEI code
549300Q8B2D2AE8GCW21
Details of transaction
Type of financial instrument Name ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Trading venue
Subscription right EQL Pharma TR SE0011844166 Exercise decrease 38,622 Quantity 0.00 SEK 13/11/2018 SPOTLIGHT STOCK MARKET
BTA EQL Pharma BTA SE0011844174 Subscription 6,437 Quantity 6.00 SEK 13/11/2018 SPOTLIGHT STOCK MARKET
Aggregation
Name ISIN code Nature of transaction Transaction date Trading venue Volume Weighted average price
EQL Pharma TR SE0011844166 Exercise decrease 13/11/2018 SPOTLIGHT STOCK MARKET 38,622 (Quantity) 0.00 SEK
EQL Pharma BTA SE0011844174 Subscription 13/11/2018 SPOTLIGHT STOCK MARKET 6,437 (Quantity) 6.00 SEK
<< Back